PRAX FY 2024 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M+249.5% YoY

Gross Profit

-$144M-1682.0% margin

Operating Income

-$200M-2340.3% margin

Net Income

-$183M-2137.5% margin

EPS (Diluted)

$-10.21

Cash Flow

Operating Cash Flow

-$132M

Free Cash Flow

-$132M

Stock-Based Comp.

$41M

Balance Sheet

Total Assets

$483M

Total Liabilities

$38M

Stockholders' Equity

$445M

Cash & Equivalents

$215M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$2M	+249.5%
Gross Profit	-$144M	-$84M	-70.6%
Operating Income	-$200M	-$126M	-58.4%
Net Income	-$183M	-$123M	-48.3%